Casa di Cura Privata del Policlinico Igea S.p.A

Milan 20144

0 studies enrolling now · 1 studies all time

What they study most

Relapsing-remitting Multiple Sclerosis (RRMS)

Studies at this site

• Comparison Between ABP 692 and Ocrevus® (Ocrelizumab) — Running, not enrolling